Decoding muscle weakness: from hidden causes to precise diagnoses

Muscle weakness, though common in clinical practice, presents significant diagnostic challenges due to its extensive range of possible underlying conditions. Notably, about 5% of U.S. adults aged 60 and above experience true muscle weakness, which must be distinguished from general fatigue or motor impairment caused by pain. An accurate diagnosis begins with differentiating true motor weakness and should involve a systematic approach including history-taking, physical examination, and objective strength testing using tools like the Medical Research Council Manual Muscle Testing scale.

The etiology of muscle weakness is broad, spanning neurologic, endocrine, infectious, genetic, and toxic causes. Neurologic sources include conditions affecting the upper and lower motor neurons, such as amyotrophic lateral sclerosis, which involves both and shows progression from one limb to generalized weakness. Disorders of the neuromuscular junction, like myasthenia gravis, present with classic fatigable weakness, often worsening throughout the day. Differential diagnoses should also account for inflammatory myopathies, endocrine dysfunctions such as thyroid disorders, and metabolic imbalances including hypokalemia.

A thorough physical examination and laboratory workup, including creatine kinase levels and imaging like MRI when necessary, are pivotal for narrowing down potential causes. Advanced tests like electromyography or even muscle biopsy may be warranted when common tests yield inconclusive results, especially for diagnosing myopathies. Moreover, assessing drug history is crucial as medications such as statins and fluoroquinolones are known culprits of muscle weakness.